tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMRN Stock Latest News

BioMarin rises 21.4%
The FlyBioMarin rises 21.4%
27m ago
BMRN
Midday Fly By: Nike reports Q2 beat, TikTok to sell U.S. unit
PremiumThe Fly
Midday Fly By: Nike reports Q2 beat, TikTok to sell U.S. unit
28m ago
BB
LW
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
57m ago
BB
AMD
BioMarin’s Amicus Acquisition: Leveraging Rare-Disease Assets and IP Extension to Drive Blockbuster Growth and Support a Buy Rating
PremiumRatings
BioMarin’s Amicus Acquisition: Leveraging Rare-Disease Assets and IP Extension to Drive Blockbuster Growth and Support a Buy Rating
2h ago
BMRN
BioMarin rises 16.7%
PremiumThe Fly
BioMarin rises 16.7%
2h ago
BMRN
BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
PremiumMarket NewsBioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
3h ago
BMRN
FOLD
BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio
Premium
Company Announcements
BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio
3h ago
8K
BMRN
Amicus jumps 30% to $14.16 after buyout offer from BioMarin
Premium
The Fly
Amicus jumps 30% to $14.16 after buyout offer from BioMarin
4h ago
BMRN
FOLD
BioMarin sees Amicus acquisition accretive to EPS in first year post close
PremiumThe Fly
BioMarin sees Amicus acquisition accretive to EPS in first year post close
5h ago
BMRN
FOLD
BioMarin to acquire Amicus for $14.50 per share in cash, or $4.8B
PremiumThe Fly
BioMarin to acquire Amicus for $14.50 per share in cash, or $4.8B
5h ago
BMRN
FOLD
BioMarin to acquire Amicus for $14.50 per share in cash, or $4.8B
PremiumThe Fly
BioMarin to acquire Amicus for $14.50 per share in cash, or $4.8B
5h ago
BMRN
FOLD
BioMarin Names New Chief Accounting Officer
PremiumCompany Announcements
BioMarin Names New Chief Accounting Officer
2d ago
8K
BMRN
BioMarin downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyBioMarin downgraded to Market Perform from Outperform at Leerink
16d ago
BMRN
BioMarin downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
BioMarin downgraded to Market Perform from Outperform at Leerink
16d ago
BMRN
BioMarin downgraded to Hold at Stifel on Voxzogo concerns
Premium
The Fly
BioMarin downgraded to Hold at Stifel on Voxzogo concerns
1M ago
BMRN
BioMarin downgraded to Hold from Buy at Stifel
PremiumThe Fly
BioMarin downgraded to Hold from Buy at Stifel
1M ago
BMRN
BioMarin price target lowered to $88 from $95 at Bernstein
PremiumThe Fly
BioMarin price target lowered to $88 from $95 at Bernstein
2M ago
BMRN
BioMarin: FDA accepts for Priority Review sBLA for Palynziq
PremiumThe Fly
BioMarin: FDA accepts for Priority Review sBLA for Palynziq
2M ago
BMRN
Biomarin’s Acquisition Strategy: Navigating Risks and Challenges for Future Growth
PremiumCompany Announcements
Biomarin’s Acquisition Strategy: Navigating Risks and Challenges for Future Growth
2M ago
BMRN
BioMarin’s Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsBioMarin’s Earnings Call: Growth Amid Challenges
2M ago
BMRN
BioMarin price target lowered to $80 from $90 at Truist
Premium
The Fly
BioMarin price target lowered to $80 from $90 at Truist
2M ago
BMRN
BioMarin price target lowered to $66 from $70 at RBC Capital
Premium
The Fly
BioMarin price target lowered to $66 from $70 at RBC Capital
2M ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >